Conduit Price Cash Flow Ratio vs Free Cash Flow Yield Analysis

CDTTW Stock   0.01  0.0001  0.89%   
Conduit Pharmaceuticals financial indicator trend analysis is way more than just evaluating Conduit Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Conduit Pharmaceuticals is a good investment. Please check the relationship between Conduit Pharmaceuticals Price Cash Flow Ratio and its Free Cash Flow Yield accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Conduit Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Conduit Stock please use our How to Invest in Conduit Pharmaceuticals guide.

Price Cash Flow Ratio vs Free Cash Flow Yield

JavaScript chart by amCharts 3.21.1520162018202020222024-4K-3.5K-3K-2.5K-2K-1.5K-1K-5000 00.050.100.150.200.250.300.350.400.450.500.550.600.650.700.750.80
JavaScript chart by amCharts 3.21.15Price Cash Flow Ratiototal: -37.8KFree Cash Flow Yieldtotal: 1.6359707926253662

Price Cash Flow Ratio vs Free Cash Flow Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Conduit Pharmaceuticals Price Cash Flow Ratio account and Free Cash Flow Yield. At this time, the significance of the direction appears to have almost identical trend.
Price Cash Flow RatioFree Cash Flow YieldDiversified AwayPrice Cash Flow RatioFree Cash Flow YieldDiversified Away100%
The correlation between Conduit Pharmaceuticals' Price Cash Flow Ratio and Free Cash Flow Yield is 0.93. Overlapping area represents the amount of variation of Price Cash Flow Ratio that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of Conduit Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Conduit Pharmaceuticals' Price Cash Flow Ratio and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price Cash Flow Ratio of Conduit Pharmaceuticals are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Price Cash Flow Ratio i.e., Conduit Pharmaceuticals' Price Cash Flow Ratio and Free Cash Flow Yield go up and down completely randomly.

Correlation Coefficient

0.93
Relationship DirectionPositive 
Relationship StrengthVery Strong

Price Cash Flow Ratio

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.
Most indicators from Conduit Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Conduit Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Conduit Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Conduit Stock please use our How to Invest in Conduit Pharmaceuticals guide.At this time, Conduit Pharmaceuticals' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to climb to 4.49 in 2025, whereas Selling General Administrative is likely to drop slightly above 4.1 M in 2025.
 2010 2024 2025 (projected)
Cost Of Revenue1.5B1.4B1.2B
Gross Profit922.2M830.0M737.8M

Conduit Pharmaceuticals fundamental ratios Correlations

1.01.01.01.01.01.01.01.00.110.591.00.741.01.00.81.00.761.00.84-0.090.950.70.810.84-0.95
1.01.01.01.01.01.01.01.00.110.591.00.741.01.00.81.00.761.00.84-0.090.950.70.810.84-0.95
1.01.01.01.01.01.01.01.00.110.591.00.741.01.00.81.00.761.00.84-0.090.950.70.810.83-0.95
1.01.01.01.01.01.01.01.00.110.591.00.741.01.00.81.00.761.00.84-0.090.950.70.810.84-0.95
1.01.01.01.01.01.01.01.00.120.591.00.741.01.00.81.00.761.00.85-0.10.950.70.810.84-0.95
1.01.01.01.01.01.01.01.00.110.591.00.741.01.00.81.00.761.00.84-0.090.950.70.810.83-0.95
1.01.01.01.01.01.01.01.00.120.591.00.741.01.00.81.00.761.00.84-0.10.950.70.810.83-0.95
1.01.01.01.01.01.01.01.00.110.61.00.751.01.00.81.00.761.00.85-0.090.950.710.820.84-0.95
1.01.01.01.01.01.01.01.00.110.591.00.741.01.00.81.00.761.00.84-0.090.950.70.810.84-0.95
0.110.110.110.110.120.110.120.110.11-0.440.110.140.110.110.690.110.420.110.14-1.00.110.140.140.14-0.11
0.590.590.590.590.590.590.590.60.59-0.440.60.830.590.60.190.590.60.590.770.460.650.830.780.78-0.48
1.01.01.01.01.01.01.01.01.00.110.60.751.01.00.81.00.761.00.85-0.090.950.710.820.84-0.95
0.740.740.740.740.740.740.740.750.740.140.830.750.740.750.650.740.920.740.95-0.120.81.00.960.95-0.61
1.01.01.01.01.01.01.01.01.00.110.591.00.741.00.81.00.761.00.84-0.090.950.70.810.84-0.95
1.01.01.01.01.01.01.01.01.00.110.61.00.751.00.81.00.771.00.85-0.090.950.710.820.84-0.95
0.80.80.80.80.80.80.80.80.80.690.190.80.650.80.80.80.830.80.72-0.670.760.620.70.72-0.76
1.01.01.01.01.01.01.01.01.00.110.591.00.741.01.00.80.761.00.84-0.090.950.70.810.84-0.95
0.760.760.760.760.760.760.760.760.760.420.60.760.920.760.770.830.760.760.96-0.40.720.920.960.96-0.72
1.01.01.01.01.01.01.01.01.00.110.591.00.741.01.00.81.00.760.85-0.090.950.70.810.84-0.95
0.840.840.840.840.850.840.840.850.840.140.770.850.950.840.850.720.840.960.85-0.120.80.941.01.0-0.8
-0.09-0.09-0.09-0.09-0.1-0.09-0.1-0.09-0.09-1.00.46-0.09-0.12-0.09-0.09-0.67-0.09-0.4-0.09-0.12-0.09-0.12-0.12-0.120.09
0.950.950.950.950.950.950.950.950.950.110.650.950.80.950.950.760.950.720.950.8-0.090.760.770.79-0.8
0.70.70.70.70.70.70.70.710.70.140.830.711.00.70.710.620.70.920.70.94-0.120.760.950.94-0.57
0.810.810.810.810.810.810.810.820.810.140.780.820.960.810.820.70.810.960.811.0-0.120.770.951.0-0.77
0.840.840.830.840.840.830.830.840.840.140.780.840.950.840.840.720.840.960.841.0-0.120.790.941.0-0.79
-0.95-0.95-0.95-0.95-0.95-0.95-0.95-0.95-0.95-0.11-0.48-0.95-0.61-0.95-0.95-0.76-0.95-0.72-0.95-0.80.09-0.8-0.57-0.77-0.79
Click cells to compare fundamentals

Conduit Pharmaceuticals Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Conduit Stock Analysis

When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Discover investing ideas

Utilize additional investing modules

News Freq…Investor S…